In summary, IL-6, IL-10, CD3-CD16+CD56+ cells, anti-EBV-NA-IgG and ferritin are potential biomarkers for the early differentiation between EBV-HLH and EBV-IM. The gene discussed is NCAM1; the disease is hemophagocytic syndrome.